127 related articles for article (PubMed ID: 34941061)
1. Ovarian high-grade serous carcinoma with elevated β-human chorionic gonadotropin: A case report.
Zhong Y; Chen X; Huang Y; Jiang Y; Chen T; Nie X; Cheng W
Medicine (Baltimore); 2021 Dec; 100(51):e28144. PubMed ID: 34941061
[TBL] [Abstract][Full Text] [Related]
2. Combination of serum hCG beta and p53 tissue expression defines distinct subgroups of serous ovarian carcinoma.
Vartiainen J; Lassus H; Lehtovirta P; Finne P; Alfthan H; Butzow R; Stenman UH
Int J Cancer; 2008 May; 122(9):2125-9. PubMed ID: 18098286
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of the β subunit of human chorionic gonadotropin promotes the transformation of human ovarian epithelial cells and ovarian tumorigenesis.
Guo X; Liu G; Schauer IG; Yang G; Mercado-Uribe I; Yang F; Zhang S; He Y; Liu J
Am J Pathol; 2011 Sep; 179(3):1385-93. PubMed ID: 21763678
[TBL] [Abstract][Full Text] [Related]
4. Elevated beta human chorionic gonadotropin in a non-pregnant female diagnosed with anal squamous cell carcinoma.
Pokharel K; Gilbar PJ; Mansfield SK; Nair LM; So A
J Oncol Pharm Pract; 2020 Jul; 26(5):1266-1269. PubMed ID: 31840564
[TBL] [Abstract][Full Text] [Related]
5. Identification of choriocarcinoma by the hCG beta-to-hCG proportion in patients with delayed diagnosis caused by contraceptive use.
Vartiainen J; Alfthan H; Lehtovirta P; Stenman UH
Contraception; 1998 Apr; 57(4):257-60. PubMed ID: 9649918
[TBL] [Abstract][Full Text] [Related]
6. [β-Human chorionic gonadotropin (HCG) dosage and lung cancer: a pitfall when screening patients for clinical trials].
Khobta N; Tomasini P; Garcia ME; Garcia S; Barlesi F
Bull Cancer; 2012 Nov; 99(11):1065-8. PubMed ID: 23017787
[TBL] [Abstract][Full Text] [Related]
7. Sister Mary Joseph nodule as cutaneous manifestations of metastatic ovarian cancer: A case report and review of the literature.
Nie X; Chen X; Jiang Y; Zhong Y; Chen T; Cheng W
Medicine (Baltimore); 2022 Feb; 101(6):e28712. PubMed ID: 35147092
[TBL] [Abstract][Full Text] [Related]
8. Tertiary cytoreduction for recurrent ovarian carcinoma: An updated and expanded analysis.
Manning-Geist BL; Chi DS; Long Roche K; Zivanovic O; Sonoda Y; Gardner GJ; O'Cearbhaill RE; Abu-Rustum NR; Leitao MM
Gynecol Oncol; 2021 Aug; 162(2):345-352. PubMed ID: 34045053
[TBL] [Abstract][Full Text] [Related]
9. Bevacizumab, Carboplatin and Paclitaxel Combination Treatment in Advanced Stage Ovarian Cancer: The First Experience in Thammasat University Hospital, Thailand: A Case Report.
Suwannarurk K; Thaweekul Y; Mairaing K; Poomtavorn Y; Tangtiang K; Piyawang W; Bhamarapravatana K
J Med Assoc Thai; 2015 Apr; 98 Suppl 3():S121-5. PubMed ID: 26387399
[TBL] [Abstract][Full Text] [Related]
10. Measurement of human chorionic gonadotropin-related immunoreactivity in serum, ascites and tumour cysts of patients with gynaecologic malignancies.
Grossmann M; Hoermann R; Gocze PM; Ott M; Berger P; Mann K
Eur J Clin Invest; 1995 Nov; 25(11):867-73. PubMed ID: 8582453
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the sensitivity and specificity of serum level of prostasin, CA125, LDH, AFP, and hCG+β in epithelial ovarian cancer patients.
Bastani A; Asghary A; Heidari MH; Karimi-Busheri F
Eur J Gynaecol Oncol; 2017; 38(3):418-424. PubMed ID: 29693884
[TBL] [Abstract][Full Text] [Related]
12. Intraplacental choriocarcinoma coexisting with fetomaternal hemorrhage: Case report, chemotherapy management, and literature review.
She Q; Cheng Z; El-Chaar D; Luo F; Guo X; Wen SW
Medicine (Baltimore); 2018 Apr; 97(14):e9977. PubMed ID: 29620671
[TBL] [Abstract][Full Text] [Related]
13. β-hCG promotes epithelial ovarian cancer metastasis through ERK/MMP2 signaling pathway.
Wu W; Gao H; Li X; Peng S; Yu J; Liu N; Zhan G; Zhu Y; Wang K; Guo X
Cell Cycle; 2019 Jan; 18(1):46-59. PubMed ID: 30582718
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors for maximally or optimally cytoreduced stage III nonserous epithelial ovarian carcinoma treated with carboplatin/paclitaxel chemotherapy.
Cuylan ZF; Meydanli MM; Sari ME; Akbayir O; Celik H; Dede M; Sahin H; Gungorduk K; Kuscu E; Ozgul N; Gungor T; Ayhan A
J Obstet Gynaecol Res; 2018 Jul; 44(7):1284-1293. PubMed ID: 29727055
[TBL] [Abstract][Full Text] [Related]
15. Human chorionic gonadotropin β regulates epithelial-mesenchymal transition and metastasis in human ovarian cancer.
Liu N; Peng SM; Zhan GX; Yu J; Wu WM; Gao H; Li XF; Guo XQ
Oncol Rep; 2017 Sep; 38(3):1464-1472. PubMed ID: 28713970
[TBL] [Abstract][Full Text] [Related]
16. Urothelial carcinoma of the prostate with raised β-hCG levels: a case report.
Sołek J; Kalwas M; Sobczak M; Dębska-Szmich S; Kupnicki P; Jesionek-Kupnicka D
J Med Case Rep; 2022 Jun; 16(1):238. PubMed ID: 35701835
[TBL] [Abstract][Full Text] [Related]
17. Urinary chorionic gonadotropin subunits and beta-core in nonpregnant women. A study of benign and malignant gynecologic disorders.
Neven P; Iles RK; Lee CL; Hudson CN; Shepherd JH; Chard T
Cancer; 1993 Jun; 71(12):4124-30. PubMed ID: 7685240
[TBL] [Abstract][Full Text] [Related]
18. Urinary human chorionic gonadotropin free beta-subunit and beta-core fragment: a new marker of gynecological cancers.
Cole LA; Wang YX; Elliott M; Latif M; Chambers JT; Chambers SK; Schwartz PE
Cancer Res; 1988 Mar; 48(5):1356-60. PubMed ID: 3342414
[TBL] [Abstract][Full Text] [Related]
19. Paraaortic node recurrence 25 years after removal of epithelial ovarian carcinoma.
Otsuka I; Shoji K
J Obstet Gynaecol Res; 2016 Nov; 42(11):1609-1612. PubMed ID: 27641229
[TBL] [Abstract][Full Text] [Related]
20. Salvage chemotherapy in recurrent platinum-resistant or refractory epithelial ovarian cancer with Carboplatin and distearoylphosphatidylcholine pegylated liposomal Doxorubicin (lipo-dox®).
Khemapech N; Oranratanaphan S; Termrungruanglert W; Lertkhachonsuk R; Vasurattana A
Asian Pac J Cancer Prev; 2013; 14(3):2131-5. PubMed ID: 23679331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
